← SynDRA
NAVTEMADLIN
SynDRA canonical compound SYN0037828 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MDM2 |
|---|
| Mechanism of action | MDM inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- MDM inhibitor
- MDM2 MODULATOR
Cross-references
Synonyms
- AMG-232
- KRT-232
- MDM2 INHIBITOR AMG-232
- 2016-06-07: AMG-232
- AMG232
- AMG 232
- Mdm2 inhibitor amg-232
- KRT 232
- 7R7G6EH5UL
- KRT232
- RefChem:927524
- MDM2 Inhibitor KRT-232
- DTXCID101509921
- Navtemadlin [USAN]
- C28H35Cl2NO5S
- DRLCSJFKKILATL-YWCVFVGNSA-N
- Navtemadlin; AMG232
- Navtemadlin [WHO-DD]
- NAVTEMADLIN [INN]
- Navtemadlin (USAN/INN)
- UNII-7R7G6EH5UL
- orb1296183
- SCHEMBL9993310
- SCHEMBL29529853
- GTPL11133
- GLXC-90179
- EX-A9371
- BDBM50448947
- EBC-54209
- MFCD28009440
- NSC781515
- NSC789723
- WHO 11546
- AKOS030526440
- compound 2 [PMID: 24456472]
- CS-3282
- NSC-781515
- NSC-789723
- NCGC00387801-04
Look up NAVTEMADLIN in the interactive SynDRA portal →